The molecular pathophysiology of obesity-driven ECM remodelling has been extensively studied and attributed to inflammation, hypoxia, renin-angiotensin-aldosterone system (RAAS), TGF-β signalling, and oxidative stress (Fig. 2). Here, TGFB1 is linked to obesity disorder.